Nexentis Technologies Inc.

Research Nexentis Technologies Inc. (NXTS) on Bullrun: market cap USD 937.38K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 937.38K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 4.00M-USD 3.82Mn/a-60.27USD 3.83MUSD 992.00KUSD 16.01M
FY2024USD 0-USD 5.19M-USD 3.42Mn/a-194.18USD 1.92MUSD 7.00KUSD 4.75M
FY2023USD 263.00K-USD 6.52M-USD 3.23M79.1%-1330.35USD 4.45MUSD 48.00KUSD 6.48M
FY2022USD 394.00K-USD 5.74M-USD 5.15M59.8%-2658.25USD 5.70MUSD 106.33KUSD 5.85M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-16USD 937.38Kn/an/an/a
20252025-12-31USD 4.66Mn/an/an/a
20242024-12-31USD 2.99Mn/an/an/a
20232023-12-29USD 2.94Mn/an/an/a
20222022-12-30USD 842.54Mn/an/an/a
20212021-12-31USD 2.76Bn/an/an/a

About Nexentis Technologies Inc.

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform;

Related stock research

Other Basic Materials stocks

Frequently asked questions

What is Nexentis Technologies Inc.'s market cap?

Nexentis Technologies Inc.'s market capitalization is USD 937.38K.

What does Nexentis Technologies Inc. do?

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects.